The market of animal drug compounding is expected to reach a value of $1.7 billion in the next 9 years, according to a report by market analysts, Transparency Market Research. Pain management and anesthesia in veterinary care as well as increased access to formulations for compounding and expectations for customizability are projected to propel market growth.
According to the report, compounds customized to an induvial pet have become popular and point to opportunities for growth. For instance, equine medication that meets customer and patient needs is uncommon, including adequate education on storage, administration, dosage, and in meeting guidelines for sports. This has increased demand for compounding medications.
At the same time, owners of companion animals are calling for better options in pet care, and alternatives to expensive medications.
List
Add
Please enter a comment